This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Drug metabolism enzymes as biomarker of disease susceptibility in Parkinson's disease.
Photo by Thought Catalog on Unsplash
First report of defects in drug metabolism in Parkinson's disease patients.
This page is a summary of: Xenobiotic metabolism in Parkinson's disease, Neurology, July 1989, Wolters Kluwer Health,
DOI: 10.1212/wnl.39.7.883.
You can read the full text:
Be the first to contribute to this page
Otolaryngology
We use a model to estimate the macroeconomic effect of head and neck cancer for countries across the world. We also look at the relationship between surgical workforce and outcomes for head and nec...
Language Speech and Hearing Services in Schools
Solution Focus Brief Therapy is a framework that guides children to identify stuttering problems and empowers them to implement practical and sustainable solutions, with the guidance of their SLP. ...
Acta Neurologica Scandinavica
This paper deals with the prognosis of epilepsy that started in children 2-16 years of age with no mayor neurological impairment. They were followed up 29-35 years later when 149 of them (65%) answ...
